Research Library

By Anshul Bhatnagar, Jingbo Niu, Vivian Ho, Wolfgang C. Winkelmayer and Kevin Erickson

Recent initiatives aim to improve…

By Kevin F. Erickson, Melandrea Worsley and Wolfgang C. Winkelmayer

Fifty years ago, on October 30, then-President…

Observations that peritoneal dialysis (PD) may be an effective, lower-cost alternative to hemodialysis for the treatment of ESKD have led to policies encouraging PD and subsequent increases in its use in the United States.

Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.

Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?

To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.

The authors found that six months of pre–end-stage kidney disease nephrology care did not significantly improve the likelihood that patients would remain employed when they started dialysis. This finding underscores the need to identify effective methods to help patients stay employed when they transition to dialysis.

Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.

Consolidated dialysis markets have coincided with both positive and negative trends in health care costs and outcomes. If the underlying mechanisms that contributed to past consolidation persist, dialysis markets may remain highly concentrated over the long term.

In this study, the authors investigate where U.S. patients with limited health insurance coverage receive maintenance dialysis. Journal of the American Society of Nephrology: http://bit.ly/2Q15Jpt